Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ambrilia Biopharma, a biotechnology company engaged in the discovery and development of novel treatments for viral diseases and cancer, has announced that it intends to initiate a plan aiming to significantly reduce its activities in France.
Subscribe to our email newsletter
As the divestment strategy is progressing, the company might concentrate all of its activities in its headquarters in Montreal and thus, further preserve its cash into 2009.
The company is following the process defined by the French employment laws for its eight permanent employees based in France.